| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (C.M.-R., M.J.G., B.D.R., S.K., H.Y., M.B.), Baltimore, Maryland 21224; the Institute of Developmental Biology, Russian Academy of Science (P.A.), Moscow, Russia; and the Department of Medicine, Johns Hopkins University (M.A.L., W.S.), Baltimore, Maryland 21205
Address all correspondence and requests for reprints to: Chahrzad Montrose-Rafizadeh, Ph.D., Eli Lilly & Co., Lilly Corporate Center, Drop Code 1543, Indianapolis, Indiana 46285. E-mail: montrose{at}lilly.com
Chinese hamster ovary (CHO) cells stably expressing the human insulin
receptor and the rat glucagon-like peptide-1 (GLP-1)
receptor (CHO/GLPR) were used to study the functional coupling of the
GLP-1 receptor with G proteins and to examine the
regulation of the mitogen-activated protein (MAP) kinase signaling
pathway by GLP-1. We showed that ligand activation of
GLP-1 receptor led to increased incorporation of
GTP-azidoanilide into Gs
, Gq/11
, and
Gi1,2
, but not Gi3
. GLP-1
increased p38 MAP kinase activity 2.5- and 2.0-fold over the basal
level in both CHO/GLPR cells and rat insulinoma cells (RIN 104638),
respectively. Moreover, GLP-1 induced phosphorylation of
the immediate upstream kinases of p38, MKK3/MKK6, in CHO/GLPR and RIN
104638 cells. Ligand-stimulated GLP-1 receptor produced
1.45- and 2.7-fold increases in tyrosine phosphorylation of 42-kDa
extracellular signal-regulated kinase (ERK) in CHO/GLPR and RIN
104638 cells, respectively. In CHO/GLPR cells, these effects of
GLP-1 on the ERK and p38 MAP kinase pathways were
inhibited by pretreatment with cholera toxin (CTX), but not with
pertussis toxin. The combination of insulin and GLP-1
resulted in an additive response (1.6-fold over insulin alone) that was
attenuated by CTX. In contrast, the ability of insulin alone to
activate these pathways was insensitive to either toxin. Our study
indicates a direct coupling between the GLP-1 receptor and
several G proteins, and that CTX-sensitive proteins are required for
GLP-1-mediated activation of MAP kinases.
This article has been cited by other articles:
![]() |
D. A. Glauser and W. Schlegel Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic {beta} cells FASEB J, October 1, 2007; 21(12): 3240 - 3249. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Jang, Z. Kokrashvili, M. J. Theodorakis, O. D. Carlson, B.-J. Kim, J. Zhou, H. H. Kim, X. Xu, S. L. Chan, M. Juhaszova, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 PNAS, September 18, 2007; 104(38): 15069 - 15074. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsunekawa, N. Yamamoto, K. Tsukamoto, Y. Itoh, Y. Kaneko, T. Kimura, Y. Ariyoshi, Y. Miura, Y. Oiso, and I. Niki Protection of pancreatic {beta}-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies J. Endocrinol., April 1, 2007; 193(1): 65 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Reimer Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. J. Endocrinol., October 1, 2006; 191(1): 159 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K K Sidhu, R C Fowkes, R H Skelly, and J M Burrin Exogenous expression of glucagon-like peptide 1 receptor and human insulin in AtT-20 corticotrophs confers cAMP-mediated gene transcription and insulin secretion J. Endocrinol., December 1, 2005; 187(3): 419 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vazquez, I. Roncero, E. Blazquez, and E. Alvarez The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation J. Endocrinol., July 1, 2005; 186(1): 221 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jorgensen, L. Martini, T. W. Schwartz, and C. E. Elling Characterization of Glucagon-Like Peptide-1 Receptor {beta}-Arrestin 2 Interaction: A High-Affinity Receptor Phenotype Mol. Endocrinol., March 1, 2005; 19(3): 812 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. List and J. F. Habener Glucagon-like peptide 1 agonists and the development and growth of pancreatic {beta}-cells Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E875 - E881. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rashid, B. F. O'Dowd, and S. R. George Minireview: Diversity and Complexity of Signaling through Peptidergic G Protein-Coupled Receptors Endocrinology, June 1, 2004; 145(6): 2645 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Brubaker and D. J. Drucker Minireview: Glucagon-Like Peptides Regulate Cell Proliferation and Apoptosis in the Pancreas, Gut, and Central Nervous System Endocrinology, June 1, 2004; 145(6): 2653 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ehses, V. R. Casilla, T. Doty, J. A. Pospisilik, K. D. Winter, H.-U. Demuth, R. A. Pederson, and C. H. S. McIntosh Glucose-Dependent Insulinotropic Polypeptide Promotes {beta}-(INS-1) Cell Survival via Cyclic Adenosine Monophosphate-Mediated Caspase-3 Inhibition and Regulation of p38 Mitogen-Activated Protein Kinase Endocrinology, October 1, 2003; 144(10): 4433 - 4445. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hui, A. Nourparvar, X. Zhao, and R. Perfetti Glucagon-Like Peptide-1 Inhibits Apoptosis of Insulin-Secreting Cells via a Cyclic 5'-Adenosine Monophosphate-Dependent Protein Kinase A- and a Phosphatidylinositol 3-Kinase-Dependent Pathway Endocrinology, April 1, 2003; 144(4): 1444 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gomez, C. Pritchard, and T. P. Herbert cAMP-dependent Protein Kinase and Ca2+ Influx through L-type Voltage-gated Calcium Channels Mediate Raf-independent Activation of Extracellular Regulated Kinase in Response to Glucagon-like Peptide-1 in Pancreatic beta -Cells J. Biol. Chem., December 6, 2002; 277(50): 48146 - 48151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ehses, S. L. Pelech, R. A. Pederson, and C. H. S. McIntosh Glucose-dependent Insulinotropic Polypeptide Activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway J. Biol. Chem., September 27, 2002; 277(40): 37088 - 37097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. McLaughlin, C. D. Thulin, S. M. Bray, M. M. Martin, T. S. Elton, and B. M. Willardson Regulation of Angiotensin II-induced G Protein Signaling by Phosducin-like Protein J. Biol. Chem., September 13, 2002; 277(38): 34885 - 34895. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Abraham, C. A. Leech, J. C. Lin, H. Zulewski, and J. F. Habener Insulinotropic Hormone Glucagon-Like Peptide-1 Differentiation of Human Pancreatic Islet-Derived Progenitor Cells into Insulin-Producing Cells Endocrinology, August 1, 2002; 143(8): 3152 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. G. Chepurny, M. A. Hussain, and G. G. Holz Exendin-4 as a Stimulator of Rat Insulin I Gene Promoter Activity via bZIP/CRE Interactions Sensitive to Serine/Threonine Protein Kinase Inhibitor Ro 31-8220 Endocrinology, June 1, 2002; 143(6): 2303 - 2313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buteau, S. Foisy, C. J. Rhodes, L. Carpenter, T. J. Biden, and M. Prentki Protein Kinase C{zeta} Activation Mediates Glucagon-Like Peptide-1-Induced Pancreatic {beta}-Cell Proliferation Diabetes, October 1, 2001; 50(10): 2237 - 2243. [Abstract] [Full Text] |
||||
![]() |
X. Wang, J. Zhou, M. E. Doyle, and J. M. Egan Glucagon-Like Peptide-1 Causes Pancreatic Duodenal Homeobox-1 Protein Translocation from the Cytoplasm to the Nucleus of Pancreatic {beta}-Cells by a Cyclic Adenosine Monophosphate/Protein Kinase A-Dependent Mechanism Endocrinology, May 1, 2001; 142(5): 1820 - 1827. [Abstract] [Full Text] |
||||
![]() |
D. M. Kemp and J. F. Habener Insulinotropic Hormone Glucagon-Like Peptide 1 (GLP-1) Activation of Insulin Gene Promoter Inhibited by p38 Mitogen-Activated Protein Kinase Endocrinology, March 1, 2001; 142(3): 1179 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ebinger, D. R. Jehle, R. D. Fussgaenger, H. C. Fehmann, and P. M. Jehle Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E88 - E94. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, J. M. Egan, B. D. Rodgers, M. Bernier, and C. Montrose-Rafizadeh Differential Expression of a Novel Seven Transmembrane Domain Protein in Epididymal Fat from Aged and Diabetic Mice Endocrinology, June 1, 1999; 140(6): 2859 - 2867. [Abstract] [Full Text] |
||||
![]() |
B. Yusta, R. P. Boushey, and D. J. Drucker The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway J. Biol. Chem., November 3, 2000; 275(45): 35345 - 35352. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Daniel, T. J. Kieffer, C. A. Leech, and J. F. Habener Novel Alternatively Spliced Exon in the Extracellular Ligand-binding Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Type 1 Receptor (PAC1R) Selectively Increases Ligand Affinity and Alters Signal Transduction Coupling during Spermatogenesis J. Biol. Chem., April 13, 2001; 276(16): 12938 - 12944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Vila Petroff, J. M. Egan, X. Wang, and S. J. Sollott Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes Circ. Res., August 31, 2001; 89(5): 445 - 452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |